<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>ANTIMICROBIAL AGENTS CHEMOTHERAPY, Sept. 2001, p. 2553&#226;&#8364;&#8220;2558                                                                                  Vol. 45,  9 <br /> 0066-4804/01/$04.00&#226;&#171;&#185;0 DOI: 10.1128/AAC.45.9.2553&#226;&#8364;&#8220;2558.2001 <br /> Copyright &#194;&#169; 2001, American Society Microbiology. Rights Reserved. <br />  <br />  <br />  <br />    Limonene Arrests Parasite Development Inhibits Isoprenylation <br />                 Proteins Plasmodium falciparum <br />              IVAN CRUZ MOURA,1&#226;&#8364;&#160; GERHARD WUNDERLICH,1 MARIA L. UHRIG,2 ALICIA S. COUTO,2 <br />                     VALNICE J. PERES,1 ALEJANDRO M. KATZIN,1 EMI&#194;&#180;LIA  KIMURA1* <br />        Departamento Parasitologia, Instituto Cie&#203;&#8224;ncias Biome&#194;&#180;dicas, Universidade Sa           &#203;&#339;o Paulo, Brazil,1                                                                                             &#203;&#339;o Paulo, Sa <br />            CIHIDECAR, Departamento Qu&#196;&#177;&#194;&#180;mica Orga        &#194;&#180;nica, Pabello <br />                                                                         &#194;&#180;n II, Facultad Ciencias Exactas y Naturales, <br />                                   Universidad Buenos Aires, 1428 Buenos Aires, Argentina2 <br />                         Received 9 November 2000/Returned modification 18 January 2001/Accepted 18 June 2001 <br />  <br />              Isoprenylation essential protein modification eukaryotic cells.  report Plasmodium <br />           falciparum, number proteins labeled incubation intraerythrocytic forms [3H]far- <br />           nesyl <span id='am-24' about='obo:IMR_0200280' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-25' property="oboInOwl:hasDbXref" content="KEGG:C00013" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="Pyrophosphate" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:id" content="IMR:0200280" datatype="xsd:string"></span>pyrophosphate</span> [3H]geranylgeranyl pyrophosphate. layer chromatography, showed           attached isoprenoids partially modified dolichol  uncharacterized, residues, confirming active <br />           isoprenoid metabolism parasite. Incubation blood-stage P. falciparum treated isoprenylation <br />           inhibitor limonene significantly decreased parasites&#226;&#8364;&#8482; progression ring stage trophozoite <br />           stage 1.22 mM, 50% parasites died cycle. Using Ras- Rap-specific monoclonal <br />           antibodies, putative Rap Ras proteins P. falciparum immunoprecipitated. treatment 0.5 <br />           mM limonene, isoprenylation proteins significantly decreased, possibly explaining observed <br />           arrest parasite development. <br />  <br />  <br />    Malaria, major tropical disease caused protozoa                  nylgeranylation farnesylation protozoan parasite P. <br /> genus Plasmodium, affects 300 500 million people                         falciparum test monoterpene limonene, causes deaths 1 million individuals year,                nontoxic inhibitor prenyl protein transferase enzyme <br /> African children 10 years age. Plasmodium falcipa-                     initially used tumor cells (1, 36), active <br /> rum, virulent species infect humans,                 fast-growing malaria parasite P. falciparum. associated potentially fatal disease (37). major <br /> clinical symptoms disease stem destruction                                           MATERIALS METHODS <br /> red blood cells multiplication asexual parasites,                    Parasite culture. experiments performed isolate (S20) P. <br /> leading anemia, cytoadherence parasitized red blood                    falciparum obtained patient living Porto Velho (State Rondo     &#203;&#8224;nia, <br />                                                                                 Brazil) (18). Parasites cultivated method Trager Jensen (33) <br /> cells endothelial receptors, resulting severe forms ma- <br />                                                                                 modified Kimura et al. (19). <br /> laria (26). expanding resistance para-                     Parasite development multiplication monitored microscopic eval- <br /> sites virtually reagents used malaria therapy,                 uation Giemsa-stained smears. Synchronization obtained new approaches drug design urgently needed. iden-                    treatments 6% (wt/vol) Plasmagel (Laboratoire Roger Bellon, Neuilly sur <br /> tification potential targets essential parasite&#226;&#8364;&#8482;s            Seine, France) solution physiological saline (28). Starting asynchronous <br />                                                                                 cultures, schizonts concentrated flotation Plasmagel subcultured <br /> life cycle prerequisite rational drug development.                     fresh erythrocytes 48-h intervals. Ring (1 20 h reinvasion), <br />    Protein prenylation general phenomenon eukaryotic                    trophozoite (20 30 h reinvasion), schizont (30 45 h reinva- <br /> cells recently detected parasites like Giardia lamblia               sion) forms purified 40 70 80% discontinuous Percoll (Pharmacia <br /> (22), Trypanosoma brucei (12), Schistosoma mansoni (6).                     LKB, Uppsala, Sweden) gradient (2). <br />                                                                                    Inhibition tests. (&#226;&#171;&#185;)-Limonene, diluted methanol  Sigma Chem- P. falciparum, Chakrabarti et al. detected protein prenyl <br />                                                                                 icals, St. Louis, Mo.), used concentrations 0.05 5.0 mM different <br /> transferase activities (5). Additionally, Rab <span id='am-11' about='obo:IMR_0001354' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-12' property="oboInOwl:hasAlternativeId" content="IMR:0200086" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0001354" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasDbXref" content="KEGG:C00044" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-16' property="rdfs:label" content="GTP" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasExactSynonym" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>GTP</span>-binding pro-                  experiments. Controls methanol performed parallel. <br /> teins (Rab6) cloned P. falciparum (21, 34) car-                      method Desjardins et al. (10) used determine 50 90% <br /> boxyl-terminal motif Cys-AAX  letter initially                      inhibitory concentrations (IC50 IC90) limonene. Briefly, ring-stage para- <br /> signified aliphatic <span id='am-29' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-30' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-34' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-35' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span>amino acid</span> letter X denoted                   site cultures (5% hematocrit, 2% parasitemia) exposed increasing drug <br />                                                                                 concentrations (0.05, 0.1, 0.2, 0.5, 1.0, 2.0, 5.0 mM). 24 h culture, <br /> undefined amino acid) Cys-Cys residues, suggests                      [G-3H]<span id='am-36' about='obo:IMR_0200173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-37' property="rdfs:label" content="Hypoxanthine" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:id" content="IMR:0200173" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasDbXref" content="KEGG:C00262" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>hypoxanthine</span> (270 GBq/mmol, 7.3 Ci/mmol; Amersham Life Sciences, prenylated. Finally, Jomaa et al. demon-                       Buckinghamshire, United Kingdom) added (5 &#226;?&#174;Ci/ml, final radioactivity <br /> strated alternative isopentenyl synthesis pathway far                  level), additional 24-h incubation period, cells harvested. scribed algae cyanobacteria, effi-                    tests triplicate. Suspensions uninfected erythrocytes similarly <br />                                                                                 treated used background subtraction. Parasitemia parasite mor- <br /> ciently inhibited fosmidomycin (17). <br />                                                                                 phology determined examining Giemsa-stained smears immediately <br />    aims work characterize protein gera-                     start assay end  IC50 calculated                                                                                 probit analysis (Minitab Statistical Software 13.30; Minitab ). <br />                                                                                    Inhibition tests 0.5 mM limonene carried flat micro- <br />   * Corresponding author. Mailing address: Universidade Sa&#203;&#339;o                 titer plates (Falcon). Freshly synchronized cultures 5% hematocrit 1% <br /> Paulo, Av. Professor Lineu Prestes, 1374, CEP 05508-900, Sa&#203;&#339;o Paulo,            parasitemia (ring-stage parasites) exposed dilutions com- <br /> Brazil. Phone: (55) (11) 38187330. Fax: (55) (11) 38187417. E-mail:             pound tested normal culture medium. 24, 48, 72 h  address: eakimura@usp.br.                                                       stated), percentage form determined. counting, <br />   &#226;&#8364;&#160; Present address: Institut National la Sante&#194;&#180; et la Recherche          value form expressed percentage total number dicale U25, Necker Ho  &#203;&#8224;pital, 75743 Paris, France.                          parasites (multinuclear schizont-infected red blood cells counted single <br />  <br />                                                                          2553 <br />  2554       MOURA ET AL.                                                                                                ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br /> cells). results independent tests evaluated significant <br /> discrepancies form time point treated versus untreated parasites Student&#226;&#8364;&#8482;s t test. <br />    Metabolic labeling. Mixed cultures P. falciparum parasitemias 10% left untreated treated 0.5 mM (&#226;&#171;&#185;)-limonene 20 h labeled presence absence drug 18 h [1-(n)-3H]gera- <br /> nylgeranyl pyrophosphate triammonium salt ([3H]GGPP; 16.5 Ci/mmol, 6.25 <br /> &#226;?&#174;Ci/ml; Amersham) [1-(n)-3H]farnesyl pyrophosphate triammonium salt <br /> ([3H]FPP; 16.5 Ci/mmol, 6.25 &#226;?&#174;Ci/ml; Amersham) RPMI 1640 normal  <br /> dium. protocol used parasites labeled 25 &#226;?&#174;Ci    35 <br /> L-[ S]methionine (&#226;&#172;&#381;1,000Ci/mmol; Amersham) ml 10 mM methionine- <br /> deficient RPMI medium. stage  ring, trophozoite, schizont form) purified described  followed lysis cells twice volume ice-cold 10 mM Tris-HCl (pH 7.2)&#226;&#8364;&#8220;150 mM NaCl&#226;&#8364;&#8220;2% (vol/vol) Triton <br /> X-100&#226;&#8364;&#8220;1 mM phenylmethylsulfonyl fluoride&#226;&#8364;&#8220;5 mM iodoacetamide&#226;&#8364;&#8220;1 mM N&#226;?&#163;-p- <br /> tosyl-<span id='am-19' about='obo:IMR_0200140' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-20' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasDbXref" content="KEGG:C00047" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="L-Lysine" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:id" content="IMR:0200140" datatype="xsd:string"></span>L-lysine</span> chloromethyl ketone&#226;&#8364;&#8220;1 &#226;?&#174;g leupeptin ml. incubation 15 min 4&#194;&#176;C, lysates centrifuged 10,000 &#226;&#171;&#187; g 30 min supernatants stored liquid N2 subsequent sodium dodecyl sulfate (SDS)-polyacryl- <br /> amide gel electrophoresis (PAGE) analysis (7, 19). <br />    layer chromatography (TLC). SDS-PAGE analysis, gel bands cor- <br /> responding labeled proteins 21 24 kDa (labeled [3H]GGPP [3H]FPP) excised, resuspended separately 0.6 ml 0.5% (vol/vol) formic <br /> acid, centrifuged remove insoluble components. supernatant transferred new tube evaporated. Cleavage reactions performed 0.1 ml ICH3 room temperature 48 h dark, 0.03 ml 35% <br /> (wt/vol) Na2CO3 added, samples kept dark                 FIG. 1. Treatment P. falciparum vitro cultures 0.5 mM <br /> additional 12 h. Samples extracted chloroform-methanol (9:1,       limonene metabolic labeling [3H]GGPP [3H]FPP. Para- <br /> vol/vol), organic phases separated dried evaporation (11,        sites treated 24 h presence (&#226;&#171;&#185;) absence (&#226;&#171;&#186;) 0.5 <br /> 30).                                                                                 mM limonene labeled 18 h 6.25 &#226;?&#174;Ci [3H]GGPP      Reverse-phase TLC (RP-TLC) performed C18 RP-precoated plates               [3H]FPP (B) ml, lysed, analyzed SDS-PAGE (12.5% acryl- <br /> (Merck, Darmstadt, Germany) using acetonitrile-methanol (1:1, vol/vol)        amide) fluorography. R, ring forms; T, trophozoites; S, schizonts. <br /> developing solvent. Authentic standards farnesol, geranylgeraniol, doli-      Lanes 1 panels B identically processed material chol used previously described (7).                                          noninfected erythrocytes. Molecular mass (Mr) standards indicated <br />    Gel electrophoresis. SDS-PAGE performed 12.5% gels described            left. (C) Parasites treated 20 h 0.5 mM limonene (20). number drug-treated untreated parasites            (&#226;&#171;&#185;) left untreated (&#226;&#171;&#186;) labeled [35S]methionine 18 h, <br /> mentioned solubilized SDS sample buffer applied       harvested, washed, lysed, analyzed SDS-PAGE (12.5% acryl- analysis. gels treated Amplify (Amersham), dried, exposed      amide). (D) Radiochromatogram chloroform-methanol (9:1)-ex- Kodak X-Omat film intensifying screen sets &#226;&#171;&#186;70&#194;&#176;C.                         tractable P. falciparum proteins products derived [3H]FPP- <br />    Immunoprecipitation assays. Samples stored liquid N2 resuspended       [3H]GGPP-labeled P. falciparum proteins resolved SDS-PAGE <br /> immunoprecipitation buffer (1% [vol/vol] Triton X-100, 150 mM NaCl, 0.5%             resolved RP-TLC. Lanes: 1, moieties cleaved 21- [wt/vol] sodium deoxycholate, 0.1% [wt/vol] SDS, 50 mM Tris-HCl [pH 8.0],        24-kDa proteins labeled [3H]GGPP; 2, moieties cleaved 21- protease inhibitor cocktail [0.2 mM phenylmethylsulfonyl fluoride, 1 mM ben-       24-kDa proteins labeled [3H]FPP; 3, control containing cleaved <br /> zamidine, 2 mM &#226;?&#164;-mercaptoethanol, 5 mg chymostatin ml, 1 &#226;?&#174;g           material 21- 24-kDa region noninfected, [3H]GGPP- <br /> leupeptin, antipain, pepstatin ml]) precleared protein       labeled red blood cells. Standards run parallel indicated Sepharose beads (Pharmacia) (27). Parasites purified schizont stage         left. FOH, farnesol; GGOH, geranylgeraniol; ori, origin. incubated anti-human Ras anti-Rap/Krev-1 monoclonal im- <br /> munoglobulins (1:50 dilution; Santa Cruz Biotechnology, ) 2 h 4&#194;&#176;C. antigen-antibody complex precipitated using 100 &#226;?&#174;l 10% protein Sepharose slurry. washes phosphate-buffered saline, bound      phozoite stages. Noninfected red blood cells showed incor- <br /> antigen released SDS sample buffer analyzed SDS-PAGE               poration radioactivity conditions (Fig. 1A autoradiography.                                                                     B, lanes 1). Importantly, signal observed                                                                                      gel composed high-molecular-weight proteins                                   RESULTS                                            material did enter gel extended electro- <br />                                                                                      phoresis low-percentage gels (data shown). <br />    P. falciparum proteins labeled incubation                            RP-TLC dephosphorylated isoprenoids reveals different <br /> [3H]FPP [3H]GGPP.  examined spectrum                              attached isoprenoid moieties. order identify isoprenoid <br /> isoprenylated polypeptides different stages P. falciparum.                     moieties attached P. falciparum proteins, bands 21 <br /> Parasites incubated [3H]FPP [3H]GGPP 18 h,                          24 kDa (labeled [3H]GGPP [3H]FPP) excised, <br /> purified Percoll gradient, lysed, analyzed SDS-                          cleaved ICH3, submitted RP-TLC iso- <br /> PAGE autoradiography. shown Fig. 1A B,                               prene standards. shown Fig. 1D, [3H]GGPP-labeled par- <br /> number putative isoprene-labeled polypeptides ob-                            asites contained proteins attached [3H]geranylgeranyl served. [3H]GGPP-labeled proteins molecular masses                           [3H]dolichol moieties undefined isoprenoid rest (lane <br /> approximately 7 kDa, approximately 10 kDa, 21 24 kDa                          1), [3H]FPP labeling parasites led 20- 24-kDa <br /> appeared ring, trophozoite, schizont stages,                         proteins containing [3H]farnesyl moieties faint radioactivity incorporated cluster 21-                    signal [3H]geranylgeranyl (lane 2). indicates 24-kDa proteins (Fig. 1A). parasites incubated                             differently labeled isoprenylated proteins [3H]FPP, similar pattern detected additional                       present 20- 24-kDa cluster [3H]GGPP 50-kDa protein labeled (Fig. 1B). analysis,                         transformed P. falciparum [3H]dolichol  <br /> tected stronger labeling schizonts ring tro-                      undefined, isoprenoid intermediate. <br />  VOL. 45, 2001                                                             PRENYLATION P. FALCIPARUM PROTEINS                         2555 <br />  <br />  <br />    Treatment parasites limonene decreases incor- <br /> poration isoprenyl precursors proteins. assess effect limonene treatment P. falciparum, compared incorporation labeled isoprenoid precursors identical <br /> amounts protein extracts obtained different purified <br /> stages P. falciparum left untreated treated 0.5 mM <br /> limonene. Treatment parasites 0.5 mM limonene dur- <br /> ing [3H]FPP labeling significantly decreased incorporation [3H]FPP proteins. effect dramatic &#226;&#172;&#8225;10-kDa band seen trophozoite schizont extracts (Fig. <br /> 1B, lane 4 versus lane 5 lane 6 versus lane 7). Labeling parasites [3H]GGPP did result differences labeling patterns (Fig. 1A), &#226;&#172;&#8225;10-kDa band inten- <br /> sity appeared lower schizont-stage parasites (Fig. <br />                                                                        FIG. 2. Monoterpene treatment partially arrests P. falciparum  <br /> 1A, lane 7). Importantly, labeled proteins originated P.       velopment ring stage. Parasite forms cultures treated falciparum parasite extracts accidentally contam-      0.5 mM limonene untreated cultures plotted inating leukocytes concentrated Percoll gradient purifica-       time culture. value form given percentage tion schizonts (leukocytes colocalize schizont-infected     sum forms time interval independent exper- <br />                                                                     iments. C, control cultures; L, limonene-treated cultures. error <br /> erythrocytes), control sample containing red blood <br />                                                                     bars indicate standard deviations. Significantly different values (P &#226;&#172;? <br /> cells used culture run parallel showed incorporation    0.05) treated versus untreated cultures labeled stars. Black radioactivity (lanes 1 Fig. 1A B). Additionally,   stars indicate significant differences treated untreated ring-stage primary effect limonene specifically         parasites, white stars indicate significant differences treated isoprenyl protein transferases, difference bulk pro-    untreated trophozoite-stage parasites. IRBC, infected red blood cells. <br /> tein synthesis seen running [35S]methionine- <br /> labeled extracts identical numbers parasites left <br /> untreated treated 0.5 mM limonene (Fig. 1C).                trophozoite stage. observed interference develop- <br />    Limonene inhibits P. falciparum growth vitro decreas-      ment,  delayed significant effect ing progression ring stage trophozoite          visible complete cell cycle (ring, trophozoite, stage. Limonene monoterpene essential oils     schizont stages reinvasion), indicating slow turnover citrus fruits plants. D-Limonene, comprises         factors affected limonene concentration. 72-h <br /> &#226;&#172;&#381;90% orange peel oil, chemopreventive activity             interval, final parasite numbers approximately 10% rodent mammary, skin, liver, lung, forestomach          lower limonene-treated cells (data shown). <br /> cancers (1), possibly interfering isoprenoid metab-        Immunoprecipitation isoprenylated proteins. p21ras olism tumor cells, specifically inhibition       p21rap previously shown modified isopre- <br /> isoprenoid protein transferases (8). observe inhibitory       nylation. order verify P. falciparum forms effect limonene growth P. falciparum parasites,     proteins recognized anti-human Ras anti-human <br /> cultured defined numbers parasites absence pres-       Rap/Krev-1 antibodies, immunoprecipitated radiolabeled <br /> ence increasing concentrations limonene. indepen-       schizont extracts. p21h-ras protein farnesylated (4), <br /> dent determinations IC50 limonene demonstrated           -CAAX motif p21rap, small GTP-binding protein precision test  results parasitemia    encoded rap/krev-1 gene, geranylgeranylated (3, 24), uptake [G-3H]hypoxanthine parasitized erythrocytes        immunoprecipitated lysates schizont forms labeled microtiter plates similar. IC50 limonene     [3H]FPP [3H]GGPP p21h-ras anti-p21rap anti- <br /> 1.22 mM, 95% confidence interval 1.07 1.42 mM.         bodies, respectively. Figure 3A, lane 1, shows p21rap anti- way, IC90 determined 2.27 mM (95%         bodies immunoprecipitated single [3H]GGPP-labeled band <br /> confidence interval, 1.99 2.70 mM). IC90, parasites       P. falciparum lysates. Accordingly, anti-Ras antibodies <br /> died 3 h treatment.                                        immunoprecipitated [3H]FPP-labeled protein (Fig. 3A, lane <br />    determine concentration limonene interferes       2).  parasites labeled [3H]FPP, incorporation isoprenyl precursors proteins,      signal seen immunoprecipitation anti-Rap. chose 0.5 mM conditions small            result obtained labeling performed percentage parasites died overall protein synthesis      [3H]GGPP, followed immunoprecipitation anti-Ras affected. demonstrated Fig. 2, 72 h culture   (data shown).  immunoprecipitation identically presence limonene, shift ring stage      treated noninfected red blood cells did result signal <br /> trophozoite stage significantly inhibited versus    analysis SDS-PAGE autoradiography (Fig. 3A, <br /> trol parasites (P &#226;&#172;? 0.05) ring forms accumulated li-         lanes 3 4). result adds proof presence <br /> monene-treated parasites (P &#226;&#172;? 0.05). results shown         Ras- Rap-related proteins P. falciparum, described <br /> obtained independent trials starting different        (16, 23, 32). <br /> initial parasitemias ranging 1.3 3%. indicates       Ras-like protein levels decreased treatment P. concentration 0.5 mM, limonene exerted partially          falciparum parasites limonene. Gelb et al. suggested inhibitory effect P. falciparum intraerythrocytic develop-       antitumorigenic effect limonene based inhibi- <br /> ment,  progression ring stage         tion Ras protein prenylation subsequent incorrect <br />  2556      MOURA ET AL.                                                                                      ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />                                                                              50 kDa, [3H]GGPP incubation failed <span id='am-41' about='rdfs:label' typeof='owl:Thing'>label</span>                                                                              50-kDa <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>peptide</span>. Similar results obtained Giardia <br />                                                                              lamblia (22) trophozoites labeled [3H]mevalonate. <br />                                                                              authors cluster 21- 26-kDa proteins                                                                              50-kDa protein. Trypanosoma brucei (12), metabolic  <br />                                                                              corporation [3H]mevalonate resulted appearance <br />                                                                              14-kDa &#226;&#172;&#8225;46-kDa prenylated protein 21-                                                                              24-kDa protein cluster.  additional, uncharacterized, <br />                                                                              proteins range &#226;&#172;&#8225;30 kDa &#226;&#172;&#8225;69 kDa                                                                               Protein prenylation usually demonstrated meta- <br />                                                                              bolic labeling [3H]mevalonic acid;  precursor <br />                                                                              incorporated P. falciparum (5, 7, 25). Danesi et al. <br />    FIG. 3. Immunoprecipitation p21ras P. falciparum           demonstrated specific labeling farnesylated gera- <br /> schizont stage.   Infected noninfected red blood cells la-         nylgeranylated proteins human prostate cancer cell line <br /> beled [3H]FPP [3H]GGPP immunoprecipitated anti-             PC-3 (9). Despite fact eukaryotic cells incorporate <br /> p20h-rap/krev (lanes 1 3) anti-p21h-ras antibody (lanes 2 4). <br />                                                                              external precursors isoprenoid metabolism pres- <br /> Lanes 3 4 immunoprecipitation noninfected red blood <br /> cells respective antibodies. (B C) Limonene 0.5 mM           ence hydroxymethylglutaryl-coenzyme reductase inhibi- <br /> specifically inhibits protein p21h-ras prenylation protein synthe-   tors (9), observed efficient labeling previous <br /> sis. (B) Identical numbers purified lysed schizonts labeled     depletion parasites&#226;&#8364;&#8482; intracellular prenyl diphosphate <br /> [3H]FPP, treated (&#226;&#171;&#185;) limonene (0.5 mM) left untreated (&#226;&#171;&#186;),           pool (7), possibly pointing receptor-mediated uptake immunoprecipitated protein Sepharose-bound mono- <br /> clonal anti-Ras immunoglobulins analyzed SDS-PAGE                 compounds medium. Additionally, failure <br /> autoradiography. Lanes: 1, untreated parasites; 2, treated parasites.        mevalonate interpreted inability (C) Identical numbers purified lysed schizonts labeled [35S       parasite metabolize compound mevalonate <br /> thionine treated (&#226;&#171;&#185;) limonene (0.5 mM) left untreated (&#226;&#171;&#186;)        pathway probably absent P. falciparum (35). immunoprecipitated protein Sepharose-bound <br />                                                                                 studies previously hypothesized existence <br /> monoclonal anti-Ras immunoglobulins analyzed SDS-PAGE. <br /> Lanes: 1, untreated parasites; 2, treated parasites. arrowhead           protein prenylation P. falciparum.  shown indicates molecular size range Ras-like protein ex-         cell extracts P. falciparum convert mevalonate farnesyl <br /> pected.                                                                      pyrophosphate, precursor protein prenylation (25), al- <br />                                                                              extracts used trials free <br />                                                                              erythrocyte components, explaining mevalonate utiliza- <br /> cytoplasmic  membrane-associated) localization (13).                 tion tests despite absence mevalonate-process- effect demonstrated human-derived                 ing enzymes P. falciparum (17, 35). Second, using com- <br /> myeloid THP-1 lymphoid RPMI-8402 cell lines (15).                        mercially available antibodies Ras Rap <br /> Given interference progression limonene-                     proteins, known farnesylated geranylgera- <br /> treated parasites ring stage trophozoite stage,              nylated cell types, Ras- Rap-like proteins demonstrated Fig. 2, asked levels cell cycle                  identified Plasmodium parasites (32). Additionally, control-associated proteins,  Ras derivatives, influ-             demonstrated existence Rab-like proteins (16). Later, <br /> enced limonene treatment. order visualize limonene               rab6 rab11 genes cloned showed typical <br /> treatment inhibits isoprenylation putative plasmo-                prenylation sites (21, 34). recent study identified protein <br /> dial Ras analogue, immunoprecipitation experiment                    farnesyl transferase protein geranylgeranyl transferase repeated using parasites subjected 0.5 mM limonene                     activities P. falciparum (5). <br /> treatment. Immunoprecipitation identical quantities pu-                   RP-TLC analysis, confirmed nature isoprenoid <br /> rified schizont extract protein showed significant decrease             moieties attached P. falciparum proteins. finding band labeling intensities treated sample versus              little [3H]FPP transformed [3H]GGPP  <br /> untreated sample (Fig. 3B, lane 2 versus lane 1).                     ported earlier Danesi et al. human PC-3 cells. [35S]methionine-labeled extract immunoprecipitated                  study, [3H]FPP [3H]GGPP modified anti-p21h-ras, decrease band intensity               compound (9). experiments, parasites immunoprecipitated protein species, confirming treat-               labeled [3H]GGPP, detected attached [3H]geranylge- <br /> ment 0.5 mM limonene inhibited incorporation                   raniol  surprisingly, [3H]dolichol moieties. presence of farnesyl moieties (Fig. 3C). various observed bands                [3H]dolichol TLC account existence Fig. 3C result low-stringency washes immuno-                 dolichylated protein molecular mass similar precipitated material.                                                       27-kDa polypeptide described Hjertman et al. human <br />                                                                              colon carcinoma cells (14). <br />                             DISCUSSION                                          Limonene, principal component orange peel oil,                                                                              identified nontoxic agent potential cancer <br />   metabolic labeling isoprenoid precursor gera-                chemotherapy (8). model systems, limonene pre- <br /> nylgeranyl pyrophosphate farnesyl pyrophosphate,                 vents formation chemically induced tumors displays <br /> detect isoprenylated proteins P. falciparum. Incor-               significant antitumor effects (36). basis, limonene poration [3H]FPP led labeling proteins range             metabolites tested clinical trials (36). Li- approximately 7 kDa, approximately 10 kDa, 21 24 kDa,                  monene metabolites demonstrated selec- <br />  VOL. 45, 2001                                                             PRENYLATION P. FALCIPARUM PROTEINS                                  2557 <br />  <br />  <br /> tively inhibit isoprenylation 21- 26-kDa proteins,        ited non-mevalonate pathway isoprenoid synthesis P. <br /> including Ras protein (13, 15). activity fast-    falciparum (17). <br /> growing cells tumor cells, hand, presence protein prenyl transferase activities P. falcipa-                              ACKNOWLEDGMENTS <br /> rum (5), hand, assessed effects limonene       work supported grants FAPESP, CNPq, <br /> treatment parasite cultures.                                     PRONEX, UNDP/World Bank (TDR). C.M. supported <br />    order analyze effects cell metabolism depend      doctoral fellowship CAPES/CNPq. G.W., E K., isoprenylation, opted limonene concentration 2.4        M.K supported CNPq fellowships. S.C. member                                                                     Research Council Argentina (CONICET). <br /> times lower IC50. concentration allowed           thank Julio Pudles Carlos Eduardo Winter valuable <br /> analyze proteins attachment isoprenyl precursors,     comments. inhibition overall protein synthesis. Generally, labeling isoprenylated proteins decreased, signifi-                                      REFERENCES <br />  <br /> cantly labeling [3H]FPP. groups demonstrated        1. Bardon, S., K. Picard, P. Martel. 1998. Monoterpenes inhibit cell <br />                                                                         growth, cell cycle progression, cyclin D1 gene expression human <br /> equal effects limonene farnesyl transferases             breast cancer cell lines. Nutr. Cancer. 32:1&#226;&#8364;&#8220;7. <br /> geranylgeranyl transferases (13). proposed        2. Braun-Breton, C., M. Jendoubi, E. Brunet, L. Perrin, J. Scaife, L. <br />                                                                         Pereira da Silva. 1986. vivo time course synthesis processing corresponding transferases P. falciparum different          major schizont membrane polypeptides Plasmodium falciparum. Mol. mammalian relatives, explaining differential inhibi-          Biochem. Parasitol. 20:33&#226;&#8364;&#8220;43. <br /> tion limonene. Morphologically, 72 h treatment      3. Buss, J. E., L.  Quilliam, K. Kato, P. J. Casey, P.  Solski, G. Wong, R. <br />                                                                         Clark, F. McCormick, G. M. Bokoch, C. J. Der. 1991. COOH- <br /> 0.5 mM limonene, progression ring stage tro-            terminal domain Rap1A (Krev-1) protein isoprenylated sup- <br /> phozoite stage decreased, led search spe-           ports transformation H-Ras:Rap1A chimeric protein. Mol. Cell. Biol. <br /> cific factors involved process. focused members           11:1523&#226;&#8364;&#8220;1530. <br />                                                                      4. Casey, P. J., P.  Solski, C. J. Der, J. E. Buss. 1989. p21ras modified Ras superfamily, related cell cycle control         farnesyl isoprenoid. Proc. Natl. Acad. Sci. USA 86:8323&#226;&#8364;&#8220;8327. signaling cell types (14). example, depletion    5. Chakrabarti, D., T. Azam, C. DelVecchio, L. Qiu, Y.  Park, C. M. Allen. <br />                                                                         1998. Protein prenyl transferase activities Plasmodium falciparum. Mol. <br /> farnesylated Ras proteins leads arrest cell cycle,            Biochem. Parasitol. 94:175&#226;&#8364;&#8220;184. <br /> possibly subsequently incorrect localization pro-      6. Chen, G. , J. L. Bennett. 1993. Characterization mevalonate-labeled <br /> teins (31).  immunoprecipitated parasite lysates           lipids isolated parasite proteins Schistosoma mansoni. Mol. Bio- <br />                                                                         chem. Parasitol. 59:287&#226;&#8364;&#8220;292. anti-Ras anti-Rap antibodies incorporation         7. Couto,  S., E.  Kimura, V. J. Peres, M. L. Uhrig,  M. Katzin. 1999. <br /> [3H]FPP [3H]GGPP, respectively. Based results,             Active isoprenoid pathway intra-erythrocytic stages Plasmodium <br /> suggest anti-Ras-immunoprecipitable protein P.          falciparum: presence dolichols 11 12 isoprene units. Biochem. J. <br />                                                                         341:629&#226;&#8364;&#8220;637. <br /> falciparum Ras-like protein, previously Western          8. Crowell, P. L., R. R. Chang,  B. Ren, C. E. Elson, M. N. Gould. 1991. <br /> blot analysis immunofluorescence assay (32). Accordingly,           Selective inhibition isoprenylation 21- 26-kDa proteins anti- <br />                                                                         carcinogen D-limonene metabolites. J. Biol. Chem. 266:17679&#226;&#8364;&#8220;17685. protein immunoprecipitated anti-Rap immunoglobu-            9. Danesi, R., C.  McLellan, C. E. Myers. 1995. Specific labeling lins termed P. falciparum Rap-like protein.                isoprenylated proteins: application study inhibitors posttransla- <br />    utilized monoterpene inhibitor protein pre-           tional farnesylation geranylgeranylation. Biochem. Biophys. Res. Com- <br />                                                                         mun. 206:637&#226;&#8364;&#8220;643. <br /> nyl transferases limonene incorporation radio-      10. Desjardins, R. E., C. J. Canfield, J. D. Haynes, J. D. Chulay. 1979. <br /> activity P. falciparum Ras-like protein specifically            Quantitative assessment antimalarial activity vitro semiautomated <br /> creases treatment. effect demonstrated          microdilution technique. Antimicrob. Agents Chemother. 16:710&#226;&#8364;&#8220;718. <br />                                                                     11. Ericsson, J., M. Runquist,  Thelin, M. Andersson, T. Chojnacki, G. human-derived myeloid THP-1 lymphoid RPMI-8402                  Dallner. 1993. Distribution prenyltransferases rat tissues. Evidence cell lines (4). Similarly, significant [3H]FPP labeling        cytosolic trans-geranylgeranyl diphosphate synthase. J. Biol. Chem. <br />                                                                         268:832&#226;&#8364;&#8220;838. <br /> inhibition Ras-like protein limonene decrease      12. Field, H.,  Blench, S. Croft, M. C. Field. 1996. Characterisation overall precipitated proteins labeling           protein isoprenylation procyclic form Trypanosoma brucei. Mol. Biochem. [35S]methionine.                                                   Parasitol. 82:67&#226;&#8364;&#8220;80. <br />                                                                     13. Gelb, M. H., F. Tamanoi, K. Yokoyama, F. Ghomashchi, K. Esson, M. N. <br />    limonene evaluated phase 1 2 clinical                Gould. 1995. inhibition protein prenyltransferases oxygenated <br /> trials, applications doses 8 g/m2 showed apparent toxic        metabolites limonene perillyl alcohol. Cancer Lett. 91:169&#226;&#8364;&#8220;175. <br /> effect (36). Considering average corporal surface area     14. Hjertman, M., J. Wejde,  Dricu, M. Carlberg, W. J. Griffiths, J. Sjovall, <br />                                                                         O. Larsson. 1997. Evidence protein dolichylation. FEBS Lett. 416: 1.8 m2, corresponding 7 liters liquid components (29),         235&#226;&#8364;&#8220;238. dose used clinical trials corresponds concentration     15. Hohl, R. J., K. Lewis. 1995. Differential effects monoterpenes                                                                         lovastatin RAS processing. J. Biol. Chem. 270:17508&#226;&#8364;&#8220;17512. 15.5 mM.  IC90 P. falciparum calculated      16. Jambou, R.,  Zahraoui, B. Olofsson,  Tavitian, G. Jaureguiberry. 2.27 mM vitro, lies significantly        1996. Small GTP-binding proteins Plasmodium falciparum. Biol. Cell value 15.5 mM used vivo. Additionally, comparing          88:113&#226;&#8364;&#8220;121. <br />                                                                     17. Jomaa, H., J. Wiesner, S. Sanderbrand, B. Altincicek, C. Weidemeyer, M. <br /> inhibition intensities immunoprecipitation experiments            Hintz,  Turbachova, M. Eberl, J. Zeidler, H. K. Lichtenthaler, D. Soldati, <br /> tecting isoprenylated proteins, concluded concen-           E. Beck. 1999. Inhibitors non-mevalonate pathway isoprenoid <br /> tration limonene inhibits isoprenylation Plasmodium          biosynthesis antimalarial drugs. Science 285:1573&#226;&#8364;&#8220;1576. <br />                                                                     18. Katzin,  M., E. S. Kimura, C. O. Alexandre,  M. Ramos. 1991. rate human cells approximately 10 times            Detection antigens urine patients acute falciparum vivax <br /> lower, indicating limonene active Plasmo-          malaria infections.  J. Trop. Med. Hyg. 45:453&#226;&#8364;&#8220;462. <br />                                                                     19. Kimura, E. ,  S. Couto, V. J. Peres, O. L. Casal,  M. Katzin. 1996. <br /> dium human cells (8).                                      N-linked glycoproteins related schizogony intraerythrocytic <br />    Taken  findings led conclude li-           stage Plasmodium falciparum. J. Biol. Chem. 271:14452&#226;&#8364;&#8220;14461. <br /> monene nontoxic monoterpenes currently               20. Laemmli, U. K. 1970. Cleavage structural proteins assembly                                                                         head bacteriophage T4. Nature 227:680&#226;&#8364;&#8220;685. <br /> tested cancer therapy prove efficient recently     21. Langsley, G., D. Chakrabarti. 1996. Plasmodium falciparum: small <br /> described compound phosmidomycin, efficiently inhib-              GTPase rab11. Exp. Parasitol. 83:250&#226;&#8364;&#8220;251. <br />  2558       MOURA ET AL.                                                                                                         ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br /> 22. Lujan, H. D., M. R. Mowatt, G.  Chen, T. E. Nash. 1995. Isoprenyla-               synthase catalyzing single condensation isopentenyl diphos- <br />     tion proteins protozoan Giardia lamblia. Mol. Biochem. Parasitol.             phate <span id='am-6' about='obo:IMR_0200097' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-7' property="oboInOwl:id" content="IMR:0200097" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="Farnesyl diphosphate" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="KEGG:C00448" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>farnesyl diphosphate</span>. J. Biochem. (Tokyo) 114:118&#226;&#8364;&#8220;121. <br />     72:121&#226;&#8364;&#8220;127.                                                                       31.   Schulz, S., F. Buhling, S. Ansorge. 1994. Prenylated proteins lym- <br /> 23. Macary, C., C. Chauvin, J. Thelu, B. Oury, F. Santoro, P. Ambroise-                 phocyte proliferation: inhibition D-limonene related monoterpenes. Eur. <br />     Thomas. 1991. Detection homologous oncogene sequences genome                  J. Immunol. 24:301&#226;&#8364;&#8220;307. <br />     Plasmodium falciparum. C. R. Acad. Sci. Ser. III 312:37&#226;&#8364;&#8220;42.                    32.   Thelu, J., V. Bracchi, J. Burnod, P. Ambroise-Thomas. 1994. Evidence <br /> 24. Macchia, M., N. Jannitti, G. Gervasi, R. Danesi. 1996. Geranylgeranyl               expression Ras-like stage specific GTP binding homologous <br />     diphosphate-based inhibitors post-translational geranylgeranylation               protein Plasmodium falciparum. Cell. Signal. 6:777&#226;&#8364;&#8220;782. <br />     cellular proteins. J. Med. Chem. 39:1352&#226;&#8364;&#8220;1356.                                    33.   Trager, W., J. B. Jensen. 1976. Human malaria parasites continuous <br /> 25. Mbaya, B., D. Rigomier, G. G. Edorh, F. Karst, J. Schrevel. 1990. <br />                                                                                             culture. Science 193:673&#226;&#8364;&#8220;675. <br />     Isoprenoid metabolism Plasmodium falciparum intraerythro- <br />                                                                                       34.   Van Wye, J., N. Ghori, P. Webster, R. R. Mitschler, H. G. Elmendorf, K. <br />     cytic phase malaria. Biochem. Biophys. Res. Commun. 173:849&#226;&#8364;&#8220;854. <br />                                                                                             Haldar. 1996. Identification localization rab6, separation rab6 26. Miller, L. H., M. F. Good, G. Milon. 1994. Malaria pathogenesis. Science <br />                                                                                             ERD2 implications &#226;&#8364;&#8482;unstacked&#226;&#8364;&#8482; Golgi, Plasmodium falciparum. <br />     264:1878&#226;&#8364;&#8220;1883. <br /> 27. Moura,  C., J. Pudles. 1999. Plasmodium chabaudi chabaudi high                  Mol. Biochem. Parasitol. 83:107&#226;&#8364;&#8220;120. <br />     molecular mass glycoprotein translocated host cell membrane           35.   Vial, H. J. 2000. Isoprenoid biosynthesis drug targeting Apicom- <br />     non-classical secretory pathway. Eur. J. Cell Biol. 78:186&#226;&#8364;&#8220;193.                         plexa. Parasitol. Today 16:140&#226;&#8364;&#8220;141. <br /> 28. Pasvol, G., R. J. Wilson, M. E. Smalley, J. Brown. 1978. Separation <br /> </body></html>